TNYA Q1 2026 Earnings Modest EPS Miss but Stock Gains on Operational Focus NMFC Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Unchanged DFDV Q1 2026 Earnings EPS Miss and Stock Decline Reflect Ongoing Development Phase IO Biotech Q3 2025 Earnings EPS Beat Highlights Cost Discipline Amid Ongoing Pipeline Development ARTNA Q3 2025 Earnings Slight EPS Beat Amid Steady Utility Performance LIVN Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline